Knowledge gaps and emerging research areas in intrauterine growth restriction-associated brain injury

Bobbi Fleiss, Flora Wong, Fiona Brownfoot, Isabelle K. Shearer, Olivier Baud, David W. Walker, Pierre Gressens, Mary Tolcos

Research output: Contribution to journalReview ArticleResearchpeer-review

Abstract

Intrauterine growth restriction (IUGR) is a complex global healthcare issue. Concerted research and clinical efforts have improved our knowledge of the neurodevelopmental sequelae of IUGR which has raised the profile of this complex problem. Nevertheless, there is still a lack of therapies to prevent the substantial rates of fetal demise or the constellation of permanent neurological deficits that arise from IUGR. The purpose of this article is to highlight the clinical and translational gaps in our knowledge that hamper our collective efforts to improve the neurological sequelae of IUGR. Also, we draw attention to cutting-edge tools and techniques that can provide novel insights into this disorder, and technologies that offer the potential for better drug design and delivery. We cover topics including: how we can improve our use of crib-side monitoring options, what we still need to know about inflammation in IUGR, the necessity for more human post-mortem studies, lessons from improved integrated histology-imaging analyses regarding the cell-specific nature of magnetic resonance imaging (MRI) signals, options to improve risk stratification with genomic analysis, and treatments mediated by nanoparticle delivery which are designed to modify specific cell functions.

Original languageEnglish
Article number188
Number of pages24
JournalFrontiers in Endocrinology
Volume10
Issue numberMAR
DOIs
Publication statusPublished - 1 Jan 2019

Keywords

  • Brain development
  • Growth restriction
  • Neurobiology and brain physiology
  • Neuroinflammation
  • Neuroprotection

Cite this

Fleiss, Bobbi ; Wong, Flora ; Brownfoot, Fiona ; Shearer, Isabelle K. ; Baud, Olivier ; Walker, David W. ; Gressens, Pierre ; Tolcos, Mary. / Knowledge gaps and emerging research areas in intrauterine growth restriction-associated brain injury. In: Frontiers in Endocrinology. 2019 ; Vol. 10, No. MAR.
@article{302eea71871b49a2b6581bb8e53c4ff8,
title = "Knowledge gaps and emerging research areas in intrauterine growth restriction-associated brain injury",
abstract = "Intrauterine growth restriction (IUGR) is a complex global healthcare issue. Concerted research and clinical efforts have improved our knowledge of the neurodevelopmental sequelae of IUGR which has raised the profile of this complex problem. Nevertheless, there is still a lack of therapies to prevent the substantial rates of fetal demise or the constellation of permanent neurological deficits that arise from IUGR. The purpose of this article is to highlight the clinical and translational gaps in our knowledge that hamper our collective efforts to improve the neurological sequelae of IUGR. Also, we draw attention to cutting-edge tools and techniques that can provide novel insights into this disorder, and technologies that offer the potential for better drug design and delivery. We cover topics including: how we can improve our use of crib-side monitoring options, what we still need to know about inflammation in IUGR, the necessity for more human post-mortem studies, lessons from improved integrated histology-imaging analyses regarding the cell-specific nature of magnetic resonance imaging (MRI) signals, options to improve risk stratification with genomic analysis, and treatments mediated by nanoparticle delivery which are designed to modify specific cell functions.",
keywords = "Brain development, Growth restriction, Neurobiology and brain physiology, Neuroinflammation, Neuroprotection",
author = "Bobbi Fleiss and Flora Wong and Fiona Brownfoot and Shearer, {Isabelle K.} and Olivier Baud and Walker, {David W.} and Pierre Gressens and Mary Tolcos",
year = "2019",
month = "1",
day = "1",
doi = "10.3389/fendo.2019.00188",
language = "English",
volume = "10",
journal = "Frontiers in Endocrinology",
issn = "1664-2392",
publisher = "Frontiers Media",
number = "MAR",

}

Knowledge gaps and emerging research areas in intrauterine growth restriction-associated brain injury. / Fleiss, Bobbi; Wong, Flora; Brownfoot, Fiona; Shearer, Isabelle K.; Baud, Olivier; Walker, David W.; Gressens, Pierre; Tolcos, Mary.

In: Frontiers in Endocrinology, Vol. 10, No. MAR, 188, 01.01.2019.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Knowledge gaps and emerging research areas in intrauterine growth restriction-associated brain injury

AU - Fleiss, Bobbi

AU - Wong, Flora

AU - Brownfoot, Fiona

AU - Shearer, Isabelle K.

AU - Baud, Olivier

AU - Walker, David W.

AU - Gressens, Pierre

AU - Tolcos, Mary

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Intrauterine growth restriction (IUGR) is a complex global healthcare issue. Concerted research and clinical efforts have improved our knowledge of the neurodevelopmental sequelae of IUGR which has raised the profile of this complex problem. Nevertheless, there is still a lack of therapies to prevent the substantial rates of fetal demise or the constellation of permanent neurological deficits that arise from IUGR. The purpose of this article is to highlight the clinical and translational gaps in our knowledge that hamper our collective efforts to improve the neurological sequelae of IUGR. Also, we draw attention to cutting-edge tools and techniques that can provide novel insights into this disorder, and technologies that offer the potential for better drug design and delivery. We cover topics including: how we can improve our use of crib-side monitoring options, what we still need to know about inflammation in IUGR, the necessity for more human post-mortem studies, lessons from improved integrated histology-imaging analyses regarding the cell-specific nature of magnetic resonance imaging (MRI) signals, options to improve risk stratification with genomic analysis, and treatments mediated by nanoparticle delivery which are designed to modify specific cell functions.

AB - Intrauterine growth restriction (IUGR) is a complex global healthcare issue. Concerted research and clinical efforts have improved our knowledge of the neurodevelopmental sequelae of IUGR which has raised the profile of this complex problem. Nevertheless, there is still a lack of therapies to prevent the substantial rates of fetal demise or the constellation of permanent neurological deficits that arise from IUGR. The purpose of this article is to highlight the clinical and translational gaps in our knowledge that hamper our collective efforts to improve the neurological sequelae of IUGR. Also, we draw attention to cutting-edge tools and techniques that can provide novel insights into this disorder, and technologies that offer the potential for better drug design and delivery. We cover topics including: how we can improve our use of crib-side monitoring options, what we still need to know about inflammation in IUGR, the necessity for more human post-mortem studies, lessons from improved integrated histology-imaging analyses regarding the cell-specific nature of magnetic resonance imaging (MRI) signals, options to improve risk stratification with genomic analysis, and treatments mediated by nanoparticle delivery which are designed to modify specific cell functions.

KW - Brain development

KW - Growth restriction

KW - Neurobiology and brain physiology

KW - Neuroinflammation

KW - Neuroprotection

UR - http://www.scopus.com/inward/record.url?scp=85066617007&partnerID=8YFLogxK

U2 - 10.3389/fendo.2019.00188

DO - 10.3389/fendo.2019.00188

M3 - Review Article

VL - 10

JO - Frontiers in Endocrinology

JF - Frontiers in Endocrinology

SN - 1664-2392

IS - MAR

M1 - 188

ER -